Our Research
Acorda Therapeutics PDUFA Date, Pipeline Review and Third Quarter Highlights
Acorda Therapeutics, Inc. (NASDAQ: ACOR) develops therapies to restore function and improve the lives of people with neurological disorders. INBRIJA™ ...
ADMA Biologics Upcoming PDUFA Dates and Milestones
ADMA Biologics, Inc. (NASDAQ: ADMA) is a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty ...
TNS Will be Initiating Coverage 12-17-18 at 9:15 AM Eastern
Update December 16th, 2018 Initiating coverage on 12-17-18 at 9:15 AM Eastern – We will be releasing a tiny float, consumer staple small cap report, n...